Cargando…

The association between buprenorphine treatment duration and mortality: a multi‐site cohort study of people who discontinued treatment

BACKGROUND AND AIMS: Buprenorphine is an effective medication for opioid use disorder that reduces mortality; however, many patients are not retained in buprenorphine treatment, and an optimal length of treatment after which patients can safely discontinue treatment has not been identified. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glanz, Jason M., Binswanger, Ingrid A., Clarke, Christina L., Nguyen, Anh P., Ford, Morgan A., Ray, G. Thomas, Xu, Stanley, Hechter, Rulin C., Yarborough, Bobbi Jo H., Roblin, Douglas W., Ahmedani, Brian, Boscarino, Joseph A., Andrade, Susan E., Rosa, Carmen L., Campbell, Cynthia I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722535/ https://www.ncbi.nlm.nih.gov/pubmed/35815386 http://dx.doi.org/10.1111/add.15998

Ejemplares similares

Development and implementation of a prescription opioid registry across diverse health systems
por: Ray, G Thomas, et al.
Publicado: (2022)

Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems
por: Campbell, Cynthia I., et al.
Publicado: (2019)

Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis
por: Hechter, Rulin C., et al.
Publicado: (2019)

Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
por: Komatsu, Ryu, et al.
Publicado: (2022)

Opioid Overdose Risk Following Hospital Discharge Among Individuals Prescribed Long-Term Opioid Therapy: a Risk Interval Analysis
por: Lyden, Jennifer R., et al.
Publicado: (2023)

Continuation Versus Discontinuation of Buprenorphine in the Perioperative Setting: A Retrospective Study
por: Schuster, Braden, et al.
Publicado: (2022)

Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment
por: Binswanger, Ingrid A., et al.
Publicado: (2022)

Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness
por: Owen-Smith, Ashli, et al.
Publicado: (2020)

Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids
por: Claypool, Anneke L., et al.
Publicado: (2023)

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl
por: Chambers, Laura C., et al.
Publicado: (2023)

Role of buprenorphine in prolonging the duration of post-operative analgesia in percutaneous nephrolithotomy: Comparison between bupivacaine versus bupivacaine and buprenorphine combination
por: Nirmala, Jonnavithula, et al.
Publicado: (2015)

Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
por: Wang, Xi, et al.
Publicado: (2023)

Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy
por: Glanz, Jason M., et al.
Publicado: (2019)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
por: Furo, Hiroko, et al.
Publicado: (2021)

Physicians’ satisfaction with providing buprenorphine treatment
por: Knudsen, Hannah K., et al.
Publicado: (2019)

Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients
por: Hall, Sharon M, et al.
Publicado: (2018)

The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment
por: Egan, James E., et al.
Publicado: (2010)

Telehealth Utilization Is Associated with Lower Risk of Discontinuation of Buprenorphine: a Retrospective Cohort Study of US Veterans
por: Vakkalanka, J. Priyanka, et al.
Publicado: (2021)

Community Treatment Programs Take Up Buprenorphine
por: Casadonte, Paul P., et al.
Publicado: (2004)

Treatment of opioid dependence with buprenorphine: current update
por: Soyka, Michael
Publicado: (2017)

Buprenorphine and pain treatment in pediatric patients: an update
por: Vicencio-Rosas, Erendira, et al.
Publicado: (2018)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity
por: Bose, Gauruv, et al.
Publicado: (2023)

Challenges of Population-based Measurement of Suicide Prevention Activities Across Multiple Health Systems
por: Yarborough, Bobbi Jo H., et al.
Publicado: (2019)

Development and evaluation of a community-based buprenorphine treatment intervention
por: Fox, Aaron D., et al.
Publicado: (2017)

Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers
por: Calcaterra, Susan L., et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment?
por: Nielsen, Suzanne, et al.
Publicado: (2022)

Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain
por: Skaer, Tracy L
Publicado: (2014)

Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors
por: Binswanger, Ingrid A, et al.
Publicado: (2012)

A mixed methods study of HIV-related services in buprenorphine treatment
por: Knudsen, Hannah K., et al.
Publicado: (2017)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
por: Mezaache, Salim, et al.
Publicado: (2021)

Access to and Payment for Office-Based Buprenorphine Treatment in Ohio
por: Parran, Theodore V, et al.
Publicado: (2017)

Routes of non-traditional entry into buprenorphine treatment programs
por: Champagne-Langabeer, Tiffany, et al.
Publicado: (2020)

Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
por: Cameron, Courtney M., et al.
Publicado: (2021)

Buprenorphine
por: Mazurek, Jaroslaw, et al.
Publicado: (2014)

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment
por: Barry, Declan T., et al.
Publicado: (2007)

Criminal charges prior to and after initiation of office-based buprenorphine treatment
por: Harris, Elizabeth E, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o97ah8n8vgjablul3bgunedbkn